Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012798 |
---|---|
Receipt number | R000014949 |
Scientific Title | The safety and efficacy trial of nab-paclitaxel and trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancer |
Date of disclosure of the study information | 2014/01/14 |
Last modified on | 2017/01/10 17:37:09 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/01/08 23:49:55 | ||
2 | Update | 2015/01/28 13:22:29 | Email1 |
|
3 | Update | 2017/01/10 17:37:09 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |